Verastem (VSTM) Debt to Equity (2017 - 2026)

Verastem (VSTM) recorded quarterly Debt to Equity of $0.89 in Q1 2026, down 33.0% quarter-over-quarter from $1.33 in Q4 2025, and up 140.57% on a YoY basis from $0.37 in Q1 2025.

Verastem (VSTM) Debt to Equity (2017 - 2026) Analysis & Trends

Verastem's Debt to Equity history runs 9 years deep, the most recent figure standing at $0.89 for Q1 2026.

  • In Q1 2026, Debt to Equity rose 140.57% year-over-year to $0.89; the TTM figure through Mar 2026 stood at $0.89 (up 140.57% YoY), while the FY2025 annual figure was $1.33, up 194.68% from the prior year.
  • Debt to Equity was $0.89 for Q1 2026 at Verastem, down from $1.33 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $3.66 in Q3 2024 to a low of -$5.03 in Q3 2025.
  • Historically, Debt to Equity has averaged $0.44 across 5 years, with a median of $0.52 in 2022.
  • Biggest YoY gain for Debt to Equity was 663.5% in 2024; the steepest drop was 301.73% in 2024.
  • A 5-year view of Debt to Equity shows it stood at $0.52 in 2022, then surged by 35.0% to $0.7 in 2023, then sank by 301.73% to -$1.41 in 2024, then jumped by 194.68% to $1.33 in 2025, then plunged by 33.0% to $0.89 in 2026.
  • The last three Debt to Equity figures came in at $0.89 (Q1 2026), $1.33 (Q4 2025), and -$5.03 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.32
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Verastem 407.42 Mn 225.74 Mn 15.90 Mn 0.89

Historic Data

Download Data
DateValue
Mar 31, 2026 0.89
Dec 31, 2025 1.33
Sep 30, 2025 -5.03
Jun 30, 2025 2.06
Mar 31, 2025 -2.20
Dec 31, 2024 -1.41
Sep 30, 2024 3.66
Jun 30, 2024 2.14
Mar 31, 2024 1.60
Dec 31, 2023 0.70
Sep 30, 2023 0.48
Jun 30, 2023 0.39
Mar 31, 2023 1.20
Dec 31, 2022 0.52
Sep 30, 2022 0.39
Jun 30, 2022 0.45
Mar 31, 2022 0.33
Sep 30, 2020 0.28
Jun 30, 2020 0.31
Mar 31, 2020 0.29